检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Alexander P J Vlaar,Martin Witzenrath,Pieter van Paassen,Leo M A Heunks,Bruno Mourvillier,Sanne de Bruin,Endry H T Lim,Matthijs C Brouwer,Pieter R Tuinman,José F K Saraiva,Gernot Marx, Suzana M Lobo,Rodrigo Boldo, Jesus A Simon-Campos,Alexander D Cornet, Anastasia Grebenyuk, Johannes M Engelbrecht, Murimisi Mukansi,Philippe G Jorens,Robert Zerbib,Simon Rückinger,Korinna Pilz,Renfeng Guo,Diederik van de Beek,Niels C Riedemann

The Lancet Respiratory Medicine（2022）

引用 39|浏览11
暂无评分
摘要
InflaRx and the German Federal Government.
更多
查看译文
关键词
antibody,vilobelimab,panamo,patients,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要